Navigation Links
Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement
Date:9/10/2009

" (within the meaning of the Private Securities Litigation Act of 1995) that inherently involve risk and uncertainties. Champions Biotechnology generally uses words such as "believe," "may," "could," "will," "intend," "expect," "anticipate," "plan," and similar expressions to identify forward-looking statements. One should not place undue reliance on these forward-looking statements. The Company's actual results could differ materially from those anticipated in the forward-looking statements for many unforeseen factors. See Champions Biotechnology's Form 10-K for the fiscal year ended April 30, 2009 for a discussion of such risks, uncertainties and other factors. Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and Champions Biotechnology's future results, levels of activity, performance or achievements may not meet these expectations. The Company does not intend to update any of the forward-looking statements after the date of this press release to conform these statements to actual results or to changes in Champions Biotechnology's expectations, except as required by law.


'/>"/>
SOURCE Champions Biotechnology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Champions Biotechnology to Present at Rodman & Renshaws Eleventh Annual Healthcare Conference
2. Champions Biotechnology to Deploy its Technology to Guide Development of Oncology Therapeutic for Global Biotech Leader
3. Champions Biotechnology Reports Fiscal 2009 Full-Year Financial Results
4. Champions Biotechnology Partners with Do-Coop Technologies to Advance Its Novel Oncology Compound Into Biomerk Tumorgraft(TM) Testing
5. Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
6. Champions Biotechnology Reports Fiscal 2009 Third Quarter Financial Results
7. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
8. Champions Biotechnology and ImClone Systems Establish Agreement for Preclinical Evaluation of Oncology Drugs
9. Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share
10. Champions Biotechnology, Inc. Appoints New Board Members and Forms Management Team
11. Ferring Pharmaceuticals Announces EUFLEXXA(TM) as Title Sponsor of the National Senior Games Hockey Championships and the GeezerJock of the Year Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...LLE, Iowa, Dec. 4 Vivako... that its shareholders of record on December 1, 20...tock of HealthAmerica, Inc. that was previously ap...rica is a private Nevada corporation of which Viva...mon shares on the record date. The distribution da...
(Date:12/3/2009)..., N.Y., Dec. 3 Nikon Corporation, ...unced today that it has signed a licensing agreeme...ts to use the Stochastic Optical Reconstruction Mi...e agreement, Nikon will manufacture STORM enabled ...M name. ,, Nikon Corporation President, Mr. Mi...
(Date:12/3/2009)... Mass., Dec. 3 Inverness...l leader in enabling individuals to take charge of...diagnostics and health management, has declared a ...tible Perpetual Preferred Stock ( IMA-PB). The div...an amount per share equal to the quotient of (a) $...
(Date:12/2/2009)... YORK, Dec. 2 Reportlinker.com ann...ble in its catalogue: ,, Neurostimulation - A ...tlinker.com/p0164232/Neurostimulation---A-Global-M...ulation market stands enthused by the growing base...e-related diseases such as, Parkinson,s, and Alzhe...
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6
...,Bulletin Board: AIMM) today reported a net loss o...ed, for the three months ended September 30, 2008,...per share basic and,diluted, for the three months ...d September 30, 2008, the net loss was $216,000, o... net loss of $62,000, or break even per,share basi...
...aq: OSTE ), a leader in the emerging field of bio... today that its next generation grafting,material ...M) Bone Graft., Robert M. Wynalek, Osteotech,s Pr...line of next generation bone regeneration products...a high performing, cost,effective bone graft mater...
...HD) today announced that its executives will be sp...invited investors to participate via webcast., ...oenix, AZ Friday, November 14, 2008 at 8.00 a...Conference, New York, NY Tuesday, December 2,...s, To access the live webcasts for these events, ...
Other Biology Technology:AutoImmune Inc. Reports 2008 Third Quarter Financial Results 2AutoImmune Inc. Reports 2008 Third Quarter Financial Results 3Osteotech's Next Generation Grafting Material, MagniFuse(TM) Bone Graft, a Breakthrough in Bone Regeneration; MagniFuse(TM) Bone Graft seeks to redefine the standard of care in the U.S. bone graft substitute market estimated to be in excess of $1.2 billio 2Osteotech's Next Generation Grafting Material, MagniFuse(TM) Bone Graft, a Breakthrough in Bone Regeneration; MagniFuse(TM) Bone Graft seeks to redefine the standard of care in the U.S. bone graft substitute market estimated to be in excess of $1.2 billio 3Cepheid to Webcast Upcoming Financial Presentations 2
(Date:12/4/2009)...am (EEG) is widely used by physicians and scientis...gical disorders. However, it has remained largely ... exact view of what is happening inside the brain....ical Cybernetics in Tbingen, Germany, have now fou...ithin the brain to that measured with EEG. These f...
(Date:12/4/2009)...al model of heart cells, University of Iowa invest...zyme, calmodulin kinase II (CaM kinase), disrupts ...study, which also involved Columbia University, wa...putational Biology . , "Recently, researchers h...II as a critical regulator of the heart,s response...
(Date:12/3/2009)..., Dec. 3 BIO-key Interna...in wireless public safety and finger-based biometr...rity of its shareholders at a Special Shareholder ...y,s Law Enforcement Division to Interact911 Mobile... in favor and 1.2% were opposed. ,, (Logo: htt...
Breaking Biology News(10 mins):How to read brain activity? 2U-Iowa study helps advance heart-related research 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3Union of American Physicians and Dentists 3A Court Appointee El Sabaawi Practicing Medicine Without a License 3F 52846 1Union of American Physicians and Dentists 3A Court Appointee El Sabaawi Practicing Medicine Without a License 3F 52846 2SEQUENOM Announces Launch of MassARRAY Compact 96 System 13217 1SEQUENOM Announces Launch of MassARRAY Compact 96 System 13217 2SEQUENOM Announces Launch of MassARRAY Compact 96 System 13217 3SEQUENOM Announces Launch of MassARRAY Compact 96 System 13217 4Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 1Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 2Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 3Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 4Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 5Sanofi Pasteur Begins Shipments of Fluzone 28R 29 Influenza Virus Vaccine for 2009 2010 Seasonal Influenza 52839 6
... WHITE PLAINS, NY Babies born preterm were more t... full-term infants, according to a new analysis of...e this week in the Springer journal Maternal and C... before 37 completed weeks gestation, is a growing... Dimes. More than a half million babies are born t...
...own as neurons process information by joining into...her across junctions called synapses. But neurons ...Josh Huang, Ph.D., in a lot of cases, they connect... Dr. Huang, a professor at Cold Spring Harbor Lab...olecules guiding this highly specific neuronal tar...
...iologists from Austria and Singapore developed a t... between biology and art. In an article recently p...fasebj.org ) and scheduled for the August 2008 pri... able to coator paintviruses with proteins. This b... efficiency of some forms of gene therapy, help tr...
Other Biology News:Analysis of millions of US births shows association between birth defects and preterm birth 2Scientists discover a molecular scaffold that guides connections between brain cells 2Scientists discover a molecular scaffold that guides connections between brain cells 3Scientists 'paint' viruses to track their fate in the body 2
Rabbit Anti-Orexin Prepro Polyclonal Antibody, Unconjugated from Abcam
Anti-Human C5a / C5a des-Arg (neo-epitode) Monoclonal Antibody, Unconjugated, Clone 2952 from Cell Sciences
Rabbit Anti-Human Ubiquitin-conjugating enzyme E2N Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Anti-Acetyl CoA Carboxylase Antibody, Unconjugated from Cell Signaling Technology
Biology Products: